Table 2 Baseline and demographic data for non-PG-l vs. PG-l patients
Non-PG-l patients (n = 335) | PG-l patients (n = 751) | P value | |
|---|---|---|---|
Median (IQR) age, years | 54 (49–59) | 71 (63–79) | < 0.001 |
Age ≥ 65 years | 44 (13.1) | 557 (74.2) | < 0.001 |
Age ≥ 75 years | 26 (7.8) | 309 (41.1) | < 0.001 |
Sex (male) | 227 (82.7) | 521 (69.4) | < 0.001 |
Median (IQR) BMI, kg/m2 | 27 (24–29) | 26 (24–29) | 0.008 |
Diabetes mellitus | 21 (6.3) | 168 (22.4) | < 0.001 |
GFR < 60 mL/min/1.73m2 | 22 (6.6) | 279 (38.2) | < 0.001 |
Multivessel CAD | 47 (14.0) | 393 (52.3) | < 0.001 |
Previous bleeding | 54 (16.2) | 0 | < 0.001 |
Previous AMI | 16 (4.8) | 90 (12.0) | < 0.001 |
Previous neoplasia | 29 (8.7) | 117 (15.6) | 0.002 |
TIA | 6 (1.8) | 21 (2.8) | 0.326 |
Hypertension | 140 (41.8) | 465 (61.9) | < 0.001 |
Dyslipidemia | 109 (32.5) | 270 (36.0) | 0.276 |
Smokers | 202 (60.3) | 234 (31.2) | < 0.001 |
Ex-smokers | 42 (12.5) | 192 (25.6) | < 0.001 |
Family history of CAD | 112 (33.4) | 125 (16.6) | < 0.001 |